May 5, 2020
Bayer, NeoGenomics launch Test4TRK program to provide free genomic cancer Testing
Bayer to cover testing costs for patients with RAI-refractory (RAI-R) differentiated thyroid carcinoma (DTC) and metastatic colorectal cancer (mCRC) with high microsatellite instability (MSI-H).